Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.38 |
| ▸ | CPB1 | P15086 | 5/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | XIAP | P98170 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 2/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30359452 | 0.84 | CPB2 (0.41) | CYP1A2CPB2CPB1 | |
| SCHEMBL27974517 | 0.76 | CYP1A2 (0.46) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL4726518 | 0.74 | CYP1A2 (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL44187 | 0.74 | CYP1A2 (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL4727798 | 0.74 | CYP1A2 (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL14798187 | 0.74 | CYP1A2 (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL60911 | 0.74 | CYP1A2 (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL7001068 | 0.73 | SLC7A5 (0.44) | CYP1A2CPB2CPB1SLC7A5ALPI | |
| Hydrochloric Acid SCHEMBL6697015 | 0.73 | TYR (0.45) | CYP1A2CPB2CPB1SLC7A5SLC1A3 | |
| SCHEMBL1678922 | 0.73 | CYP1A2 (0.44) | CYP1A2CPB2CPB1SLC7A5SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110206756-A1 | DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-08-25 | — | — | US | claimed |
| US-20110182978-A1 | ACTIVATED NITRIC OXIDE DONORS AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-07-28 | — | — | US | claimed |
| US-7951846-B2 | pH-sensitive polymeric micelles for drug delivery | BAE YOU HAN | 2011-05-31 | — | — | US | claimed |
| EP-2265256-A1 | DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2010-12-29 | — | — | EP | claimed |
| EP-2262478-A2 | ACTIVATED NITRIC OXIDE DONORS AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2010-12-22 | — | — | EP | claimed |
| US-7659314-B2 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-02-09 | — | — | US | claimed |
| US-20090274753-A1 | PH-SENSITIVE POLYMERIC MICELLES FOR DRUG DELIVERY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-11-05 | — | — | US | claimed |
| WO-2009117333-A1 | DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-09-24 | — | — | WO | claimed |
| WO-2009114368-A2 | ACTIVATED NITRIC OXIDE DONORS AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-09-17 | — | — | WO | claimed |
| US-7229973-B2 | pH-sensitive polymeric micelles for drug delivery | UTAH, UNIVERSITY OF RESEARCH FOUNDATION | 2007-06-12 | — | — | US | claimed |
| US-20050186263-A1 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-08-25 | — | — | US | claimed |
| US-20050070721-A1 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-03-31 | — | — | US | claimed |
| EP-4337221-A1 | SILICONE-BASED DYES AND METHODS FOR MAKING AND USING THE SAME | University of Mississippi (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20220370641-A1 | SILICONE-BASED DYES WITH SHORT WAVELENGTH INFRARED ABSORPTION AND EMISSION AND METHODS FOR MAKING AND USING THE SAME | UNIV MISSISSIPPI (US) | 2022-11-24 | — | — | US | disclosed |
| US-20170290915-A1 | METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2017-10-12 | — | — | US | disclosed |
| US-9439915-B2 | Activated nitric oxide donors and methods of making and using thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2016-09-13 | — | — | US | disclosed |
| US-20050186263-A1 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-08-25 | — | — | US | disclosed |
| US-20050118718-A1 | Stabilization and controlled delivery of ionic biopharmaceuticals | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-06-02 | — | — | US | disclosed |
| US-20050070721-A1 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-03-31 | — | — | US | disclosed |
| US-20050070721-A1 | PH-sensitive polymeric micelles for drug delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110206756-A1 | DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF | DLST, DLAT, TTPA | CYP1A2 4860/4885CPB2 3307/4885CPB1 2334/4885 |
| US-20110182978-A1 | ACTIVATED NITRIC OXIDE DONORS AND METHODS OF MAKING AND USING THEREOF | NOS2, NOS3, NOS1 | CYP1A2 1887/4885CPB2 3988/4885CPB1 3562/4885 |
| US-20170290915-A1 | METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR | CD44, HDGF, HCCS | CYP1A2 4586/4885CPB2 650/4885CPB1 1311/4885 |
| US-20220370641-A1 | SILICONE-BASED DYES WITH SHORT WAVELENGTH INFRARED ABSORPTION AND EMISSION AND METHODS FOR MAKING AND USING THE SAME | SMARCB1, SMARCD1, SMARCA5 | CYP1A2 3175/4885CPB2 3527/4885CPB1 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.